These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 26334480

  • 21. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole.
    Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG.
    AAPS PharmSciTech; 2009; 10(3):917-23. PubMed ID: 19609836
    [Abstract] [Full Text] [Related]

  • 22. [Optimization of microemulsion containing vinpocetine and its physicochemical properties].
    Li H, Pan WS, Wu Z, Li JY, Xia LX.
    Yao Xue Xue Bao; 2004 Sep; 39(9):681-5. PubMed ID: 15606013
    [Abstract] [Full Text] [Related]

  • 23. Formulation and evaluation of flurbiprofen microemulsion.
    Ambade KW, Jadhav SL, Gambhire MN, Kurmi SD, Kadam VJ, Jadhav KR.
    Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
    [Abstract] [Full Text] [Related]

  • 24. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
    Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J.
    Cutis; 1999 Jun; 63(6):349-54. PubMed ID: 10388959
    [Abstract] [Full Text] [Related]

  • 25. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.
    Chen H, Chang X, Du D, Li J, Xu H, Yang X.
    Int J Pharm; 2006 Jun 06; 315(1-2):52-8. PubMed ID: 16600540
    [Abstract] [Full Text] [Related]

  • 26. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
    Tanghetti EA, Werschler WP, Lain E, Guenin E, Harris S, Loncaric A, Pillai R.
    J Drugs Dermatol; 2020 Mar 01; 19(3):272-279. PubMed ID: 32549090
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
    Leyden JJ.
    Cutis; 2004 Oct 01; 74(4 Suppl):9-15. PubMed ID: 15543714
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Development of Microemulsion Based Nabumetone Transdermal Delivery for Treatment of Arthritis.
    Jagdale SC, Deore GK, Chabukswar AR.
    Recent Pat Drug Deliv Formul; 2018 Oct 01; 12(2):130-149. PubMed ID: 29485013
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
    Tang-Liu DD, Matsumoto RM, Usansky JI.
    Clin Pharmacokinet; 1999 Oct 01; 37(4):273-87. PubMed ID: 10554045
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.